CBT Stock Analysis: Buy, Sell, or Hold?
CBT - Cabot Corporation
$82.09
-0.81 (-0.98%)
▼
5d:
+1.0%
30d:
+11.96%
90d:
+7.08%
BUY
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Get Alerted When CBT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CBT shows positive signals but monitor for confirmation. Market pricing in 4.8% growth. Moderate conviction.
💡 BUY OPPORTUNITY: CBT shows positive signals but monitor for confirmation. Market pricing in 4.8% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$101.62
Based on 7.4% avg growth
INTRINSIC VALUE TODAY
$63.10
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CBT is currently trading at $82.09, which is considered extended relative to its 30-day fair value range of $73.93 to $81.08. From a valuation perspective, the stock is trading at a premium (Forward PE: 11.8) compared to its historical average (10.3). At these levels, the market is pricing in 4.8% annual earnings growth.
Technical Outlook: Technically, CBT is in a uptrend. Immediate support is located at $75.16, while resistance sits at $86.43.
Market Sentiment: CBT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CBT is in a uptrend. Immediate support is located at $75.16, while resistance sits at $86.43.
Market Sentiment: CBT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$73.93 -
$81.08
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($82.20)
- BULLISH: Expecting earnings turnaround to 4.8% growth with -3.4% revenue growth
Trading Range Analysis
30-Day Trading Range
$73.93 -
$81.08
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$75.16
Resistance Level
$86.43
Current Trend
Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.85
Wall Street Target
$82.20
(+0.1%)
Revenue Growth (YoY)
-3.4%
Earnings Growth (YoY)
-24.9%
Profit Margin
8.0%
Valuation Premium vs History
+4.8% premium
PE vs Historical
11.9 vs 10.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.8%
(market-implied from PE analysis)
1-Year Target
$86.03
(+5%)
2-Year Target
$90.16
(+10%)
3-Year Target
$94.49
(+15%)
3-Yr Target (if PE normalizes)
(PE: 12→10)
PE COMPRESSION
$82.15
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 10.7%)
$207.13
(+152%)
Base:
(SPY PE: 11.8, Growth: 10.7%)
$111.34
(+36%)
Bear:
(PE: 10.1, Growth: 10.7%)
$94.64
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (16x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 15.64 | Current EPS (TTM): $5.30
Bull Case
$119.22
(+45%)
Analyst growth 30.7%, PE expands to 17.2
Base Case
$108.38
(+32%)
Market implied 30.7%, PE stable at 15.6
Bear Case
$56.37
(-31%)
Severe decline -20.0%, PE contracts to 13.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 15, 2026 2:01 AM ET
Data refreshes hourly during market hours. Next update: 3:01 AM
Data refreshes hourly during market hours. Next update: 3:01 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CBT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Specialty Chemicals Stocks
Top-rated stocks in Specialty Chemicals by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LIN
Linde plc Ordinary Shares |
BUY
28 analysts |
$540 | 65 BUY |
|
SHW
Sherwin-Williams Co |
BUY
28 analysts |
$379 | 60 BUY |
|
IFF
International Flavors & … |
STRONG BUY
22 analysts |
$91 | 58 HOLD |
|
DD
Dupont De Nemours Inc |
STRONG BUY
20 analysts |
$57 | 60 HOLD |
|
APD
Air Products and Chemica… |
BUY
24 analysts |
$328 | 60 HOLD |
